Targeting PTEN using small molecule inhibitors

Methods

Volumn 77, Issue , 2015, Pages 63-68

  Mak, Lok Hang ^a   Woscholski, Rudiger ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Inhibition; OMFP; PTEN; Vanadium compounds; VO OHpic

Indexed keywords

DRUG ANALYSIS; PHOSPHATASE AND TENSIN HOMOLOGUE DELETED ON CHROMOSOME 10 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN; SMALL MOLECULE TRANSPORT AGENT; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; CELL GROWTH; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; GENE TARGETING; GENETICS; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; METHODOLOGY; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROCEDURES; REVIEW;

ANALYSIS; ANIMALS; GENE TARGETING; GENETICS; HUMANS; METHODS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 84963958780     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2015.02.007     Document Type: Review

References (41)

1. Li J., et al. Science 1997, 275(5308):1943-1947.
2. Sun H., et al. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(11):6199-6204.
3. Cantley L.C., Neel B.G. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(8):4240-4245.
4. Di Cristofano A., Pandolfi P.P. Cell 2000, 100(4):387-390.
5. Arcaro A., Wymann M.P. Biochem. J. 1993, 296(Pt 2):297-301.
6. Vlahos C.J., et al. J. Biol. Chem. 1994, 269(7):5241-5248.
7. Petritsch C., et al. J. Biol. Chem. 1995, 270(44):26619-26625.
8. Zhang J., Yang P.L., Gray N.S. Nat. Rev. Cancer 2009, 9(1):28-39.
9. Workman P. Biochem. Soc. Trans. 2004, 32(Pt 2):393-396.
10. Schmid A.C., et al. FEBS Lett. 2004, 566(1-3):35-38.
11. Rosivatz E., et al. ACS Chem. Biol. 2006, 1(12):780-790.
12. Fujita T., et al. Br. J. Cancer 2006, 94(2):247-252.
13. Koksal I.T., et al. Urol. Oncol. 2004, 22(4):307-312.
14. Lacey J.V., et al. Cancer Res. 2008, 68(14):6014-6020.
15. Alimonti A., et al. J. Clin. Invest. 2010, 120(3):681-693.
16. Lai J.P., et al. Br. J. Pharmacol. 2009, 156(1):189-200.
17. Liu S., et al. Aging Cell 2011, 10(4):661-674.
18. Shi G.D., et al. Biochem. Biophys. Res. Commun. 2011, 404(4):941-945.
19. Sury M.D., et al. Neurobiol. Dis. 2011, 41(1):201-208.
20. Chen Z., et al. Int. J. Dev. Neurosci. 2012, 30(6):411-419.
21. Walker C.L., Xu X.M. Neurosci. Lett. 2014, 573:64-68.
22. Adhikari D., et al. PLoS One 2012, 7(6):e39034.
23. McLaughlin M., et al. Mol. Hum. Reprod. 2014, 20(8):736-744.
24. Silva S.R., et al. Anticancer Res. 2011, 31(4):1153-1160.
25. Wen P.J., et al. Nat. Commun. 2011, 2:491.
26. Zu L., et al. Eur. J. Pharmacol. 2011, 650(1):298-302.
27. Tzenaki N., et al. FASEB J. 2012, 26(6):2498-2508.
28. Zhu X., et al. PLoS One 2014, 9(4):e95622.
29. Maehama T., Taylor G.S., Dixon J.E. Annu. Rev. Biochem. 2001, 70:247-279.
30. Johnson T.O., Ermolieff J., Jirousek M.R. Nat. Rev. Drug Discov. 2002, 1(9):696-709.
31. Norris F.A., et al. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(24):14057-14059.
32. Mak L.H., et al. ACS Chem. Biol. 2011, 6(12):1382-1390.
33. Huyer G., et al. J. Biol. Chem. 1997, 272(2):843-851.
34. Stambolic V., et al. Cell 1998, 95(1):29-39.
35. Manning B.D., Cantley L.C. Cell 2007, 129(7):1261-1274.
36. Gunn R.M., Hailes H.C. J. Chem. Biol. 2008, 1(1-4):49-62.
37. Mak L.H., Vilar R., Woscholski R. J. Chem. Biol. 2010, 3(4):157-163.
38. Dowler, S., G. Kular, D.R. Alessi, Protein lipid overlay assay. Sci STKE, 2002. 2002(129): p. pl6.
39. Weiner O.D. Curr. Biol. 2002, 12(12):R429-R431.
40. Gray A., Van Der Kaay J., Downes C.P. Biochem. J. 1999, 344(Pt. 3):929-936.
41. Rosivatz E., Woscholski R. Methods Mol. Biol. 2009, 462:213-222.